GovChime
Notice ID: 92673996049f4d4aa10fb53d49de51aePresolicitationArchived

NOI to Sole Source to One Lambda, Inc.

Archived on March 30, 2026. Full description on SAM.gov.

Overview

Posted
March 23, 2026
Notice type
Presolicitation
NAICS
325413: In-Vitro Diagnostic Substance Manufacturing
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH OLAO
Place of performance
Bethesda, Maryland, 20892
Last updated
Nov 1, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
NOI-OD-26-004204
Notice ID
92673996049f4d4aa10fb53d49de51ae

Description

This is a notice of intent, not a request for a quotation.  A solicitation document will not be issued and quotations will not be requested.

The National Institutes of Health (NIH) intends to award a fixed price purchase order to One Lambda, Inc., located at 22801 Roscoe Blvd, West Hills, CA 91304, on a firm fixed price sole source award basis to provide specific HLA typing and antibody screening reagents. The HLA Lab currently uses these reagents to test our patients. The reagents provided by One Lambda have been previously tested in the lab and provide a greater ability to resolve testing ambiguities than other vendors tested. All validation testing has been completed for these reagents so there is laboratory documentation available to confirm the accuracy and precision of these reagents. A change in vendors/reagents would require extensive validation and would take approximately 2 months. This would greatly impact the ability of the HLA Lab to provide timely results. The function of the Human Leukocyte Antigen Laboratory (HLA) of the Department of Transfusion Medicine, CC is to (1) provide clinical diagnostic laboratory testing for patients in the Clinical Center to facilitate possible transplant or enrollment into an appropriate protocol for the patient’s particular condition; (2) to conduct clinical consultations for Clinical Center physicians in the management of patient care in regards to potential transplant scenarios; (3) to maintain accreditation through various accrediting agencies in order to provide quality results (4) to conduct research in the development of new diagnostic laboratory tests (5) to facilitate the support and development of protocols which involve HLA testing and the implications for patient care.

The proposed vendor, One Lambda, is the sole provider of the LABType, LABScreen, and Secore kits. No other vendors would be suitable. These exact reagents are not available from any other vendor and have been quality control tested to validate their performance. To change vendors for a similar reagent kit would require extensive testing and validation of the new reagents which would impact patient care.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Documents

Files (1)

  • NOI to Sole Source.docx

    17 KBAdded in Presolicitation version 3Posted
    Download

Lifecycle

  1. 3
    Version 3PresolicitationArchivedCurrent

    NOI to Sole Source to One Lambda, Inc.

    Notice 92673996049f4d4aa10fb53d49de51ae on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

NOI-OD-26-004204

Archive Date

Mar 30, 2026

Office Address

BETHESDA, MD, 20892